Vergunst CE - Search Results

1

CCR5 blockade in rheumatoid arthritis: a randomised, double-blind, placebo-controlled clinical trial.

van Kuijk AW, Vergunst CE, Gerlag DM, Bresnihan B, Gomez-Reino JJ, Rouzier R, Verschueren PC, van der Leij C, Maas M, Kraan MC, Tak PP. van Kuijk AW, et al. Among authors: vergunst ce. Ann Rheum Dis. 2010 Nov;69(11):2013-6. doi: 10.1136/ard.2010.131235. Epub 2010 Aug 6. Ann Rheum Dis. 2010. PMID: 20693270 Clinical Trial.

2

[Pseudogout in 3 patients with presumed therapy-resistant rheumatoid arthritis].

Vergunst CE, Tak PP. Vergunst CE, et al. Ned Tijdschr Geneeskd. 2005 Apr 2;149(14):773-7. Ned Tijdschr Geneeskd. 2005. PMID: 15835631 Dutch.

3

Chemokines: their role in rheumatoid arthritis.

Vergunst CE, Tak PP. Vergunst CE, et al. Curr Rheumatol Rep. 2005 Oct;7(5):382-8. doi: 10.1007/s11926-005-0026-7. Curr Rheumatol Rep. 2005. PMID: 16174489 Review.

4

The role of chemokines in rheumatoid arthritis and osteoarthritis.

Vergunst CE, van de Sande MG, Lebre MC, Tak PP. Vergunst CE, et al. Scand J Rheumatol. 2005 Nov-Dec;34(6):415-25. doi: 10.1080/03009740500439159. Scand J Rheumatol. 2005. PMID: 16393761 Review.

5

Blocking the receptor for C5a in patients with rheumatoid arthritis does not reduce synovial inflammation.

Vergunst CE, Gerlag DM, Dinant H, Schulz L, Vinkenoog M, Smeets TJ, Sanders ME, Reedquist KA, Tak PP. Vergunst CE, et al. Rheumatology (Oxford). 2007 Dec;46(12):1773-8. doi: 10.1093/rheumatology/kem222. Epub 2007 Oct 27. Rheumatology (Oxford). 2007. PMID: 17965442 Clinical Trial.

6

Absence of changes in the number of synovial sublining macrophages after ineffective treatment for rheumatoid arthritis: Implications for use of synovial sublining macrophages as a biomarker.

Wijbrandts CA, Vergunst CE, Haringman JJ, Gerlag DM, Smeets TJ, Tak PP. Wijbrandts CA, et al. Among authors: vergunst ce. Arthritis Rheum. 2007 Nov;56(11):3869-71. doi: 10.1002/art.22964. Arthritis Rheum. 2007. PMID: 17968928 Free article. No abstract available.

7

Modulation of CCR2 in rheumatoid arthritis: a double-blind, randomized, placebo-controlled clinical trial.

Vergunst CE, Gerlag DM, Lopatinskaya L, Klareskog L, Smith MD, van den Bosch F, Dinant HJ, Lee Y, Wyant T, Jacobson EW, Baeten D, Tak PP. Vergunst CE, et al. Arthritis Rheum. 2008 Jul;58(7):1931-9. doi: 10.1002/art.23591. Arthritis Rheum. 2008. PMID: 18576354 Free article. Clinical Trial.

8

MLN3897 plus methotrexate in patients with rheumatoid arthritis: safety, efficacy, pharmacokinetics, and pharmacodynamics of an oral CCR1 antagonist in a phase IIa, double-blind, placebo-controlled, randomized, proof-of-concept study.

Vergunst CE, Gerlag DM, von Moltke L, Karol M, Wyant T, Chi X, Matzkin E, Leach T, Tak PP. Vergunst CE, et al. Arthritis Rheum. 2009 Dec;60(12):3572-81. doi: 10.1002/art.24978. Arthritis Rheum. 2009. PMID: 19950299 Free article. Clinical Trial.

9

Why CCR2 and CCR5 blockade failed and why CCR1 blockade might still be effective in the treatment of rheumatoid arthritis.

Lebre MC, Vergunst CE, Choi IY, Aarrass S, Oliveira AS, Wyant T, Horuk R, Reedquist KA, Tak PP. Lebre MC, et al. Among authors: vergunst ce. PLoS One. 2011;6(7):e21772. doi: 10.1371/journal.pone.0021772. Epub 2011 Jul 1. PLoS One. 2011. PMID: 21747955 Free PMC article.

10

[A girl with desquamation of hands and feet].

Chung PK, Vergunst CE, van der Kuip M. Chung PK, et al. Among authors: vergunst ce. Ned Tijdschr Geneeskd. 2014;158:A7327. Ned Tijdschr Geneeskd. 2014. PMID: 24893811 Dutch.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page